Global Heparin (Heparin Sodium and Heparin Calcium) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Heparin (Heparin Sodium and Heparin Calcium) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Heparin (Heparin Sodium and Heparin Calcium) market size was valued at USD 2708.3 million in 2023 and is forecast to a readjusted size of USD 5973.2 million by 2030 with a CAGR of 12.0% during review period.

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.

Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium.

The market driver mainly increasing prevalence of conditions such as renal impairment, coronary artery disease, and venous thromboembolism, High demand for anticoagulants, etc.

In recent years, with the impact of African swine fever and the outbreak of COVID-19. Heparin as a resource-based industry expected to be in a state of tight supply for a period in the future, and the tight supply state may drive the sales price of heparin products to rise, the future driving force of the industry is more obvious, and the long-term profitability is more certain. The price of heparin has ushered in a major upward cycle since 2016. The main reason is that China is the main supplier of live pigs in the world. The raging African swine fever has greatly reduced the supply of live pigs, driving the price of heparin to rise sharply.

Asia-Pacific is the largest consumption place, with a revenue market share nearly 35% in 2022. Mainly China is the worlds’ largest pig production, which supplied by sufficient raw materials. Following Asia-Pacific, Europe is the second largest consumption place with the revenue market share nearly 34%.

The global key manufacturers of Heparin include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, Pfizer, Hebei Changshan Biochemical Pharmaceutical, Bioibérica, Qingdao Jiulong Biopharmaceutical, Changzhou Qianhong Biopharma, and etc. In 2022, the global top five players hold a share approximately 57% in terms of revenue.

The Global Info Research report includes an overview of the development of the Heparin (Heparin Sodium and Heparin Calcium) industry chain, the market status of UFH (Heparin Sodium, Heparin Calcium), LMWH (Heparin Sodium, Heparin Calcium), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Heparin (Heparin Sodium and Heparin Calcium).

Regionally, the report analyzes the Heparin (Heparin Sodium and Heparin Calcium) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Heparin (Heparin Sodium and Heparin Calcium) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Heparin (Heparin Sodium and Heparin Calcium) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Heparin (Heparin Sodium and Heparin Calcium) industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K MT), revenue generated, and market share of different by Type (e.g., Heparin Sodium, Heparin Calcium).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Heparin (Heparin Sodium and Heparin Calcium) market.

Regional Analysis: The report involves examining the Heparin (Heparin Sodium and Heparin Calcium) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Heparin (Heparin Sodium and Heparin Calcium) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Heparin (Heparin Sodium and Heparin Calcium):

Company Analysis: Report covers individual Heparin (Heparin Sodium and Heparin Calcium) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Heparin (Heparin Sodium and Heparin Calcium) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (UFH, LMWH).

Technology Analysis: Report covers specific technologies relevant to Heparin (Heparin Sodium and Heparin Calcium). It assesses the current state, advancements, and potential future developments in Heparin (Heparin Sodium and Heparin Calcium) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Heparin (Heparin Sodium and Heparin Calcium) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Heparin (Heparin Sodium and Heparin Calcium) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
Heparin Sodium
Heparin Calcium

Market segment by Application
UFH
LMWH

Major players covered
Shenzhen Hepalink Pharmaceutical
Yantai Dongcheng Pharmaceutical
Nanjing King-friend Biochemical Pharmaceutical
Pfizer
Hebei Changshan Biochemical Pharmaceutical
Bioibérica
Qingdao Jiulong Biopharmaceutical
Changzhou Qianhong Biopharma
Dongying Tiandong Pharmaceutical
Opocrin
Hubei Enoray Biopharmaceutical
Yino Pharma
Cisen Pharmaceutical
Nanjing Xinbai Pharmaceutical
Sichuan Deebio Pharmaceutical

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Heparin (Heparin Sodium and Heparin Calcium) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Heparin (Heparin Sodium and Heparin Calcium), with price, sales, revenue and global market share of Heparin (Heparin Sodium and Heparin Calcium) from 2019 to 2024.

Chapter 3, the Heparin (Heparin Sodium and Heparin Calcium) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Heparin (Heparin Sodium and Heparin Calcium) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Heparin (Heparin Sodium and Heparin Calcium) market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Heparin (Heparin Sodium and Heparin Calcium).

Chapter 14 and 15, to describe Heparin (Heparin Sodium and Heparin Calcium) sales channel, distributors, customers, research findings and conclusion.